FDA Inspection 802513 — Fresenius Kabi AB
The FDA completed an inspection of Fresenius Kabi AB on September 25, 2012 in Uppsala. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 25, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Uppsala (Sweden)